Galibier Capital Management Ltd. purchased a new stake in Nutrien Ltd (NYSE:NTR) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 454,391 shares of the company’s stock, valued at approximately $24,358,000. Nutrien accounts for about 11.1% of Galibier Capital Management Ltd.’s portfolio, making the stock its 3rd largest position. Galibier Capital Management Ltd. owned about 0.08% of Nutrien as of its most recent filing with the SEC.
Several other institutional investors also recently added to or reduced their stakes in the company. Boston Partners raised its stake in shares of Nutrien by 39.4% in the 1st quarter. Boston Partners now owns 12,584,872 shares of the company’s stock valued at $663,978,000 after acquiring an additional 3,556,556 shares during the period. TD Asset Management Inc. raised its stake in shares of Nutrien by 3.9% in the 1st quarter. TD Asset Management Inc. now owns 8,266,777 shares of the company’s stock valued at $436,127,000 after acquiring an additional 309,354 shares during the period. CIBC Asset Management Inc raised its stake in shares of Nutrien by 4.4% in the 1st quarter. CIBC Asset Management Inc now owns 7,273,792 shares of the company’s stock valued at $383,622,000 after acquiring an additional 309,472 shares during the period. Great West Life Assurance Co. Can raised its stake in shares of Nutrien by 1.0% in the 1st quarter. Great West Life Assurance Co. Can now owns 5,609,460 shares of the company’s stock valued at $294,970,000 after acquiring an additional 53,102 shares during the period. Finally, Toronto Dominion Bank raised its stake in shares of Nutrien by 94.6% in the 1st quarter. Toronto Dominion Bank now owns 5,494,159 shares of the company’s stock valued at $289,969,000 after acquiring an additional 2,671,293 shares during the period. 68.37% of the stock is currently owned by institutional investors and hedge funds.
Shares of NTR stock traded up $0.94 during trading on Friday, reaching $49.78. The company’s stock had a trading volume of 840,800 shares, compared to its average volume of 1,592,170. The company has a market capitalization of $28.00 billion, a price-to-earnings ratio of 18.51, a P/E/G ratio of 2.15 and a beta of 0.87. The stock’s 50-day moving average price is $51.81 and its 200 day moving average price is $52.39. Nutrien Ltd has a 1-year low of $43.96 and a 1-year high of $58.99.
Nutrien (NYSE:NTR) last announced its quarterly earnings data on Monday, July 29th. The company reported $1.58 earnings per share for the quarter, missing analysts’ consensus estimates of $1.59 by ($0.01). The company had revenue of $8.66 billion for the quarter, compared to analysts’ expectations of $8.17 billion. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the business earned $1.48 EPS. Sell-side analysts anticipate that Nutrien Ltd will post 2.85 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, October 17th. Shareholders of record on Monday, September 30th will be issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 3.62%. The ex-dividend date is Friday, September 27th. This is a boost from Nutrien’s previous quarterly dividend of $0.43. Nutrien’s payout ratio is 63.94%.
A number of research firms have recently issued reports on NTR. Citigroup set a $61.00 price target on shares of Nutrien and gave the company a “buy” rating in a research note on Wednesday, July 31st. Bank of America raised shares of Nutrien from an “underperform” rating to a “neutral” rating in a research note on Friday. Raymond James reissued a “strong-buy” rating and issued a $70.00 price target on shares of Nutrien in a research note on Tuesday, July 30th. TD Securities boosted their price target on shares of Nutrien from $68.00 to $69.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. Finally, Cowen restated an “outperform” rating and issued a $63.00 price objective (down previously from $66.00) on shares of Nutrien in a report on Tuesday, April 23rd. Six research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. Nutrien presently has an average rating of “Buy” and an average target price of $62.00.
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
See Also: What are popular green investing opportunities?
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.